Pri-Med Podcasts

Identifying Risk in Women to Prevent CVD - Frankly Speaking Ep 237

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-237
 
Overview: Solid evidence shows that adverse pregnancy outcomes (APOs) correlate with an increased risk of cardiovascular disease (CVD) in women. Evidence is also becoming clearer that lactation and breastfeeding may have CV protective benefits as well. Social determinants of health play a significant role in these diseases; facts support that Black, Hispanic and Asian American women suffer from worse pregnancy outcomes than White American women. Join us while we discuss the recent American Heart Association (AHA) guideline update regarding the association of increased risk of CVD and metabolic disease with APOs and what can be done to reduce these risks.
 
Episode resource links:
Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women. Nisha I. Parikh, MD, MPH, Chair, Juan M. Gonzalez, MD, Cheryl A.M. Anderson, PhD, Suzanne E. Judd, PhD, Kathryn M. Rexrode, MD, Mark A. Hlatky, MD, Erica P. Gunderson, PhD, Jennifer J. Stuart, ScD, Dhananjay Vaidya, PhD, Vice Chair, On behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. https://www.ahajournals.org/doi/abs/10.1161/CIR.000000000000096
Schwartz, EB. (reviewing Parikh NI et al. Circulation 2021 Mar 29). Preventing Heart Disease in Women: New Guidance from the American Heart Association. NEJM: Journal Watch, April 12, 2021. https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart?ijkey=3l3eCvQLl
Clinical Statements and Guidelines. AHA/ACOG Presidential Advisory. Volume 137, Issue 24, 12 June 2018, Pages e843-e852. https://doi.org/10.1161/CIR.0000000000000582
https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato

Continuous Glucose Monitoring—What’s All the Hype? - Frankly Speaking Ep 236

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-236
 
Overview: Continuous glucose monitoring (CGM) for patients with diabetes has been available for several years now, but its utility in managing diabetes care is unclear. Join us to discuss the results of a systematic review examining the benefits of CGM for patients with both type 1 and type 2 diabetes mellitus.
 
Episode resource links:
Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146-1156
Implementing Continuous Glucose Monitoring in Clinical Practice. www.aafp.org/fpm March/April 2021
Longo R, Sperling S. Personal versus professional continuous glucose monitoring: when to use which on whom. Diabetes Spectr. 2019;32(3):183-193.
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato

A Case of Severe Asthma: How Eosinophils Can Impact Asthma Evaluation and Treatment in Primary Care

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/severe-asthma-how-eosinophils-impact-evaluation-treatment Overview:  Did you know that approximately two-thirds of adults with severe asthma are eosinophilic? The presence of eosinophilia can have implications for asthma management as well. Join Dr. Nicola Hanania, pulmonologist and asthma expert, as he reviews the case of a patient with severe asthma and discusses how primary care clinicians can identify eosinophilia, using common biomarkers, and improve outcomes in patients with eosinophilic asthma. Guest: Nicola Hanania, MD, MS, FACP, FCCP, FRCPC

Nasal Steroids for Perennial Allergic Rhinitis: Is PRN Use Enough? - Frankly Speaking Ep 235

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-235
 
Overview: Perennial allergic rhinitis affects both children and adults, and management includes both allergy avoidance as well as medication management. Intranasal steroids are the mainstay of treatment and have traditionally required consistent use, but new data are emerging. Find out the results of a new study evaluating PRN use as an alternative approach.
 
Episode resource links:
Thongngarm T, Wongsa C, Phinyo P, Assanasen P, Tantilipikorn P, Sompornrattanaphan M. As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1365-1373
 
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato

Shorter Antibiotic Duration for Outpatient Infections - Frankly Speaking Ep 234

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-234
 
Overview: Many providers overtreat outpatient infections for fear of not treating until resolution or causing a complication, but this can lead to antibiotic resistance and adverse events. Join us to discuss the new ACP guidelines on antibiotic use in the outpatient setting and the pediatric treatment recommendations. Walk away with a clear understanding of the guidelines for optimal duration of antibiotic treatment for individuals with an outpatient infection.
 
Episode resource links:
ACP: Ann Intern Med. doi:10.7326/M20-7355; https://www.acpjournals.org/doi/pdf/10.7326/M20-7355
Low risk for PCN allergy: Am J Respir Crit Care Med 2020 Feb 21; [e-pub]. (https://doi.org/10.1164/rccm.202001-0089LE); Mayo Clinic Proceedings 2018, 93 (1): 101-107
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato

Taking the Distress out of Diabetes—Mindfulness and Acceptance Therapies May Help - Frankly Speaking Ep 233

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-233
 
Overview: T2DM is an epidemic, and its impact on quantity of life is well documented. In most cases, treatment involves significant lifestyle changes in combination with medication. Distress about the T2DM diagnosis and necessary behavioral changes occurs in about one-third of people, and this distress is associated with poor glycemic management. Join us as we discuss a recent meta-analysis on mindfulness and learn how cognitive therapies may be effective in reducing distress and HbA1c. 
 
Episode resource links: 
Ngan, H.Y., Chong, Y.Y. and Chien, W.T. (2021), Effects of mindfulness‐ and acceptance‐based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta‐analysis. Diabet Med, 38: e14525. https://doi.org/10.1111/dme.14525; https://onlinelibrary-wiley-com.umassmed.idm.oclc.org/doi/epdf/10.1111/dme.14525
Guest: Susan Feeney, DNP, FNP-BC, NP-C
 
Music Credit: Richard Onorato

Community-Acquired Pneumonia: How Long Do We Need to Treat? - Frankly Speaking Ep 232

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-232
 
Overview: For patients with community-acquired pneumonia (CAP), wide variation in the duration of treatment exists. Longer duration of treatment may increase the risk of adverse effects and lead to antibiotic resistance. However, shorter duration of treatment may result in treatment failure. See what new evidence shows may be the best antibiotics treatment duration in most patients with CAP.
 
Episode resource links:
Dinh A et al. Pneumonia Short Treatment (PTC) Study Group. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet. 2021 Mar 27;397(10280):1195-1203
Metlay JP et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67.
Guest: Alan Ehrlich MD, FAAFP
 
Music Credit: Richard Onorato

Pain in EVERYONE’s Neck - Frankly Speaking Ep 231

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-231
 
Overview: Who couldn’t use a refresher on how to diagnose and treat neck pain in the primary care setting? Review the techniques for assessing neck pain, determining its cause, and providing relief. Immediately apply what you learn to start helping patients with neck pain feel better.
 
Episode resource links:
Am Fam Physician 2016 May 1;93(9):746-54.
Sub occipital Release: J Electromyogr Kinesiol 2016 Oct;30:31-7. doi: 10.1016/j.jelekin.2016.05.007
Self Myofascial Release: Spine 2020 Nov 1;45(21):E1367-E1375
Guest: Robert A. Baldor MD, FAAFP/Frank
 
Music Credit: Richard Onorato

Perioperative Management for Patients Taking DOACs - Frankly Speaking Ep 230

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-230
 
Overview: Join us to discuss the results of the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) cohort study, aimed at understanding the safety of using a simplified perioperative management approach for patients with atrial fibrillation taking DOACs. After this episode, you’ll be able to make sense of the controversy over current guidelines around surgical care in this patient population. More importantly, you’ll walk away with practical knowledge to help these patients minimize their risk of adverse events.
 
Episode resource links:
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med.2019; 179(11 ): 1469-14 78. doi: 10.1001 /jamainternmed.2019.2431
 
Guest: Robert A. Baldor MD, FAAFP
 
Music Credit: Richard Onorato

Let’s Stop HIV Together & Pri-Med Part 1: 40 Year Recognition of HIV – Addressing Health Equity and Overcoming Barriers in Primary Care

Credits: 0.50 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/stop-hiv-together-1 Overview: HIV remains a persistent health problem for the United States and countries around the world. June marks 40 years since the first report of AIDS in CDC’s MMWR. Great progress has happened in the last 40 years in preventing and treating HIV. Yet there is still much to do. Join Dr. Charles Vega, Health Sciences Clinical Professor at UC Irvine Department of Family Medicine, and Dr. Oni Blackstock, primary care and HIV physician, researcher, and founder and executive director of Health Justice, racial and health equity consulting practice as they discuss how health and social inequities continue to affect the HIV epidemic. They will talk about the role primary care providers can play in ending the HIV epidemic. Guest: Oni Blackstock, MD, MHS